Effects of short-term probiotic ingestion on immune profiles and microbial translocation among HIV-1-infected Vietnamese children

International Journal of Molecular Sciences

Volumn 18, Issue 10, 2017, Pages

  Ishizaki, Azumi ^a   Bi, Xiuqiong ^a   Van Nguyen, Lam ^b   Matsuda, Kazunori ^c   Pham, Hung Viet ^b   Phan, Chung Thi Thu ^b   Khu, Dung Thi Khanh ^b   Ichimura, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL OF PEDIATRICS   (Viet Nam)

^c YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

16S 23S ribosomal DNA; HIV infected children; Immune activation; Intestinal microbial translocation; Probiotics

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD38 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; DNA 16S; DNA 23S; HEMOGLOBIN; HLA DR ANTIGEN; PROBIOTIC AGENT; RNA 16S; RNA 23S;

ANTIRETROVIRAL THERAPY; ARTICLE; BACTERIAL TRANSLOCATION; BODY HEIGHT; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FERMENTED MILK PRODUCT; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNITY; INFANT; INTESTINE FLORA; LACTOBACILLUS CASEI; MAJOR CLINICAL STUDY; MALE; NEWBORN; OPEN STUDY; PEDIATRICS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RASH; REGULATORY T LYMPHOCYTE; TH17 CELL; TH2 CELL; THROMBOCYTE COUNT; VIETNAMESE; VIRUS LOAD; CD4 CD8 RATIO; CONTROLLED CLINICAL TRIAL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MICROBIOLOGY; PRESCHOOL CHILD; VIET NAM;

CD4-CD8 RATIO; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROINTESTINAL MICROBIOME; HIV INFECTIONS; HIV-1; HUMANS; LACTOBACILLUS CASEI; MALE; PROBIOTICS; TH17 CELLS; TH2 CELLS; VIETNAM;

EID: 85032036240     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18102185     Document Type: Article

References (29)

1. Mehandru, S.; Poles, M.A.; Tenner-Racz, K.; Horowitz, A.; Hurley, A.; Hogan, C.; Boden, D.; Racz, P.; Markowitz, M. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 2004, 200, 761–770.
2. Hunt, P.W. Th17, gut, and HIV: Therapeutic implications. Curr. Opin. HIV AIDS 2010, 5, 189–193.
3. Brenchley, J.M.; Paiardini, M.; Knox, K.S.; Asher, A.I.; Cervasi, B.; Asher, T.E.; Scheinberg, P.; Price, D.A.; Hage, C.A.; Kholi, L.M.; et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008, 112, 2826–2835.
4. Gordon, S.N.; Cervasi, B.; Odorizzi, P.; Silverman, R.; Aberra, F.; Ginsberg, G.; Estes, J.D.; Paiardini, M.; Frank, I.; Silvestri, G. Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals. J. Immunol. 2010, 185, 5169–5179.
5. Estes, J.D.; Harris, L.D.; Klatt, N.R.; Tabb, B.; Pittaluga, S.; Paiardini, M.; Barclay, G.R.; Smedley, J.; Pung, R.; Oliveira, K.M.; et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010, 6, e1001052.
6. Brenchley, J.M.; Price, D.A.; Schacker, T.W.; Asher, T.E.; Silvestri, G.; Rao, S.; Kazzaz, Z.; Bornstein, E.; Lambotte, O.; Altmann, D.; et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12, 1365–1371.
7. Mehandru, S.; Poles, M.A.; Tenner-Racz, K.; Jean-Pierre, P.; Manuelli, V.; Lopez, P.; Shet, A.; Low, A.; Mohri, H.; Boden, D.; et al. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med. 2006, 3, e484.
8. Bi, X.; Suzuki, Y.; Gatanaga, H.; Oka, S. High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts. Eur. J. Immunol. 2009, 39, 301–309.
9. Hardy, H.; Harris, J.; Lyon, E.; Beal, J.; Foey, A.D. Probiotics, prebiotics and immunomodulation of gut mucosal defences: Homeostasis and immunopathology. Nutrients 2013, 5, 1869–1912.
10. Hemsworth, J.C.; Hekmat, S.; Reid, G. Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada. Gut Microbes 2012, 3, 414–419.
11. Trois, L.; Cardoso, E.M.; Miura, E. Use of probiotics in HIV-infected children: A randomized double-blind controlled study. J. Trop. Pediatr. 2008, 54, 19–24.
12. Hummelen, R.; Changalucha, J.; Butamanya, N.L.; Koyama, T.E.; Cook, A.; Habbema, J.D.; Reid, G. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes 2011, 2, 80–85.
13. Gori, A.; Rizzardini, G.; Van’t Land, B.; Amor, K.B.; van Schaik, J.; Torti, C.; Quirino, T.; Tincati, C.; Bandera, A.; Knol, J.; et al. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: Results of the “COPA” pilot randomized trial.Mucosal Immunol. 2011, 4, 554–563.
14. Gonzalez-Hernandez, L.A.; Jave-Suarez, L.F.; Fafutis-Morris, M.; Montes-Salcedo, K.E.; Valle-Gutierrez, L.G.; Campos-Loza, A.E.; Enciso-Gomez, L.F.; Andrade-Villanueva, J.F. Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: A double-blind randomized controlled pilot trial. Nutr. J. 2012, 11, 90.
15. Shida, K.; Nanno, M.; Nagata, S. Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: A possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes 2011, 2, 109–114.
16. Falasca, K.; Vecchiet, J.; Ucciferri, C.; DiNicola, M.; D’Angelo, C.; Reale, M. Effect of Probiotic Supplement onCytokine Levels inHIV-Infected Individuals: A Preliminary Study. Nutrients 2015, 7, 8335–8347.
17. Bi, X.; Ishizaki, A.; Nguyen, L.V.; Matsuda, K.; Pham, H.V.; Phan, C.T.; Ogata, K.; Giang, T.T.; Phung, T.T.; Nguyen, T.T.; et al. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam. Int. J. Mol. Sci. 2016, 17.
18. Kamada, N.; Seo, S.U.; Chen, G.Y.; Nunez, G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013, 13, 321–335.
19. Kobayashi, T.; Suzuki, T.; Kaji, R.; Serata, M.; Nagata, T.; Ando, M.; Iizuka, R.; Tsujibe, S.; Murakami, J.; Kiyoshima-Shibata, J.; et al. Probiotic upregulation of peripheral IL-17 responses does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis mouse models. Immunopharmacol. Immunotoxicol. 2012, 34, 423–433.
20. Klatt, N.R.; Canary, L.A.; Sun, X.; Vinton, C.L.; Funderburg, N.T.; Morcock, D.R.; Quinones, M.; Deming, C.B.; Perkins, M.; Hazuda, D.J.; et al. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infectedmacaques. J. Clin. Investig. 2013, 123, 903–907.
21. D’Ettorre, G.; Ceccarelli, G.; Giustini, N.; Serafino, S.; Calantone, N.; De Girolamo, G.; Bianchi, L.; Bellelli, V.; Ascoli-Bartoli, T.; Marcellini, S.; et al. Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the “Probio-HIV” Clinical Trial. PLoS ONE 2015, 10, e0137200.
22. D’Ettorre, G.; Rossi, G.; Scagnolari, C.; Andreotti, M.; Giustini, N.; Serafino, S.; Schietroma, I.; Scheri, G.C.; Fard, S.N.; Trinchieri, V.; et al. Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients. Immun. Inflamm. Dis. 2017, 5, 244–260.
23. Agustina, R.; Bovee-Oudenhoven, I.M.J.; Lukito, W.; Fahmida, U.; van de Rest, O.; Zimmermann, M.B.; Firmansyah, A.; Wulanti, R.; Albers, R.; van den Heuvel, E.G.H.M.; et al. Probiotics Lactobacillus reuteri DSM 17938 and Lactobacillus casei CRL 431 Modestly Increase Growth, but Not Iron and Zinc Status, among Indonesian Children Aged 1–6 Years. J. Nutr. 2013, 143, 1184–1193.
24. Minemura, M.; Shimizu, Y. Gut microbiota and liver diseases. World J. Gastroenterol. 2015, 21, 1691–1702.
25. Lata, J.; Jurankova, J.; Kopacova, M.; Vitek, P. Probiotics in hepatology.World J. Gastroenterol. 2011, 17, 2890–2896.
26. Trifari, S.; Kaplan, C.D.; Tran, E.H.; Crellin, N.K.; Spits, H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 2009, 10, 864–871.
27. Hunt, P.W.; Martin, J.N.; Sinclair, E.; Bredt, B.; Hagos, E.; Lampiris, H.; Deeks, S.G. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 2003, 187, 1534–1543.
28. Maecker, H.T.; McCoy, J.P.; Nussenblatt, R. Standardizing immunophenotyping for the Human Immunology Project. Nat. Rev. Immunol. 2012, 12, 191–200.
29. Kinter, A.; McNally, J.; Riggin, L.; Jackson, R.; Roby, G.; Fauci, A.S. Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc. Natl. Acad. Sci. USA 2007, 104, 3390–3395.